CABLES1 and neoplasm: Loss of CABLES1 expression is observed with high frequency in human colon, lung, ovarian, and endometrial cancers [42–45], and also enhances tumor progression in the ApcMin/+ mouse model and activates the Wnt/β-catenin signaling pathway [46].